Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Tse, Herman ^a   To, Kelvin K W ^a   Wen, Xi ^b   Chen, Honglin ^a   Chan, Kwok Hung ^c   Tsoi, Hoi Wah ^b   Li, Iris W S ^c   Yuen, Kwok Yung ^a  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GLYCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS RNA; VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FACTORIAL ANALYSIS; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; GENOTYPE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MORTALITY; NASOPHARYNGEAL ASPIRATION; RECTUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; TRACHEAL ASPIRATION PROCEDURE; VIRAL GENETICS; VIREMIA; VIROLOGY; VIRUS GENE; ADOLESCENT; GENETIC POLYMORPHISM; INFLUENZA; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; PANDEMIC; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMAGGLUTININS, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MUTATION; PANDEMICS; POLYMORPHISM, GENETIC; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIREMIA;

EID: 80053206038     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022534     Document Type: Article

References (27)

1. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, et al. (2009) Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 361: 674-679.
2. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, et al. (2009) H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 374: 451-458.
3. Hung IF, To KK, Lee CK, Lin CK, Chan JF, et al. (2010) Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009. Clin Infect Dis 51: 274-279.
4. To KK, Hung IF, Li IW, Lee KL, Koo CK, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-859.
5. Gordon CL, Johnson PD, Permezel M, Holmes NE, Gutteridge G, et al. (2010) Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 50: 672-678.
6. Mak GC, Au KW, Tai LS, Chuang KC, Cheng KC, et al. (2010) Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15.
7. World Health Organization (2010) Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec 85: 21-22.
8. Miller RR, MacLean AR, Gunson RN, Carman WF, (2010) Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill 15.
9. Kilander A, Rykkvin R, Dudman SG, Hungnes O, (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15.
10. Chen H, Wen X, To KK, Wang P, Tse H, et al. (2010) Quasispecies of the D225G substitution in the hemagglutinin of pandemic influenza A(H1N1) 2009 virus from patients with severe disease in Hong Kong, China. J Infect Dis 201: 1517-1521.
11. Oughton M, Dascal A, Laporta D, Charest H, Afilalo M, et al. (2011) Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09. Diagn Microbiol Infect Dis 70: 213-217.
12. Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, et al. (2007) Influenza viremia and the potential for blood-borne transmission. Transfusion 47: 1080-1088.
13. Kuiken T, Taubenberger JK, (2008) Pathology of human influenza revisited. Vaccine 26 (Suppl 4): D59-66.
14. Tsuruoka H, Xu H, Kuroda K, Hosaka Y, (1997) [Viremia in influenza: detection by polymerase chain reaction]. Nippon Rinsho 55: 2714-2718.
15. Naficy K, (1963) Human Influenza Infection with Proved Viremia. Report of a Case. N Engl J Med 269: 964-966.
16. Poliakova TG, Ketiladze ES, Zhilina NN, Stakhanova VM, (1970) [Viremia in influenza A2 (Hong Kong)]. Vopr Virusol 15: 724-728.
17. Stanley ED, Jackson GG, (1966) Viremia in Asian influenza. Trans Assoc Am Physicians 79: 376-387.
18. Minuse E, Willis PW 3rd, Davenport FM, Francis T Jr, (1962) An attempt to demonstrate viremia in cases of Asian influenza. J Lab Clin Med 59: 1016-1019.
19. Herzberg K, Vanek E, Reuss K, (1961) [Research on the problem of influenza viremia. II. Virus detection experiments on the blood of human influenza patients]. Z Hyg Infektionskr 147: 382-390.
20. To KK, Wong SS, Li IW, Hung IF, Tse H, et al. (2010) Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection. Postgrad Med J 86: 515-521.
21. Chan KH, Peiris JS, Lim W, Nicholls JM, Chiu SS, (2008) Comparison of nasopharyngeal flocked swabs and aspirates for rapid diagnosis of respiratory viruses in children. J Clin Virol 42: 65-69.
22. Centers for Disease Control and Prevention (CDC) (2007) CDC Realtime RT-PCR (rRTPCR) protocol for detection and characterization of influenza (version 2007). CDC REF.# I-007-05.
23. Vanholder R, Ringoir S, (1993) Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3: 1541-1554.
24. Skehel JJ, Wiley DC, (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69: 531-569.
25. Stevens J, Blixt O, Glaser L, Taubenberger JK, Palese P, et al. (2006) Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355: 1143-1155.
26. Osterlund P, Pirhonen J, Ikonen N, Ronkko E, Strengell M, et al. (2010) Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 84: 1414-1422.
27. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, et al. (2007) Infections associated with haemophagocytic syndrome. Lancet Infect Dis 7: 814-822.